Vitamin D
Evidence indicates vitamin D to be indirectly or directly a factor regarding HCV therapies’ efficacy. The necessary level required of this fat-soluble vitamin for optimum immune system function remains ill-defined. Still, many hepatitis C infections have been found to have a deficiency. While traditionally linked to bone health, recent studies suggest low vitamin levels are associated with various diseases, including cardiovascular disorders, cancer, and infections.
Some data support the supplementation of vitamin D to have a role in hepatitis C treatment and improve SVR rates. Other observational studies show the links between vitamin D deficiency and reduced rates of SVR, and another study shows a strong association between an SNP in its treatment response and binding protein. In addition, there are reports of improved results with the intervention of vitamin D.
While vitamin D may aid in preventing further damage to the liver due to hepatitis C, there isn’t any definitive evidence that shows it to be an effective treatment method for the condition. Moreover, taking supplements may cause potential compilations. For this reason, it’s best to speak to your physician before using vitamin D supplements to stay safe.
